Publications

Vural S, Baskurt D, Özcanlı A, Bozkurt EG, Danacı S, Sarıoğlu S,  Berrak YH, Başkan A, Yaylı S, Bouazzi D, Medianfar CE, Christensen R, Jemec GBE

Bouazzi D, Andersen RK, Vinding GR, Medianfar CE, Nielsen SM, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J, Christensen R, Jemec GBE. 

Introduction: Data concerning the global burden of hidradenitis suppurativa (HS) are limited. Reported prevalence estimates vary between 0.0003% and 4.1%, and data from various geographical regions are still to be collected. 

Anaba EL, Bouazzi D, Ajayi PV, Aro OO, Boer J, Jemec GBE.

Background: Epidemiologic hidradenitis suppurativa (HS) studies from Africa are lacking. This study aimed at uncovering the prevalence of HS in Lagos, Nigeria, to validate an HS screening questionnaire, and to contribute to the Global Hidradenitis Suppurativa Atlas (GHiSA).

Botvid SHC, Storgaard Hove L, Bouazzi D, Kjærsgaard Andersen R, Francis Thomsen S, Saunte DM, Jemec GBE.

Hagan PG, Bouazzi D, Nyarko G, Dartey ES, Nunoo-Ghartey KB, Nkum D, Ansu P, Boakye JY, Andersen RK, Boer J, Jemec GBE.